Spackman Media Group Artist Wi Ha-jun Stars in New Romance K-Drama Graduation & Reprises Role in SQUID GAME SEASON 2

2 years ago

Spackman Media Group artist Wi Ha-jun will headline a new romance K-drama, GRADUATION, directed by Ahn Pan-seok, who previously collaborated…

Smartsheet Invests in Australia-based Data Hosting to Better Serve Global Customer Base

2 years ago

The enterprise work management leader’s newest regional deployment will provide customers the ability to host their data onshore in Australia,…

Fabrinet to Announce First Quarter Fiscal Year 2024 Financial Results on November 6, 2023

2 years ago

BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to…

Gold Resource Corporation Announces Q3 2023 Conference Call

2 years ago

DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the “Company”) will host a conference call Friday, November 3, 2023 at 10:00…

Polaris and OrionVM Partner to Next-Gen Cloud Transform Queensland ICT Market

2 years ago

OrionVM’s MicroPoP Technology Enables Leading Australian Data Centre to Uniquely Underpin Cloud Workloads, Including Enterprise Cloud, AI and Storage Solutions…

New Chinese Restrictions on Supply of Natural Graphite Will Negatively Impact Batteries Used in EV Market

2 years ago

Westwater Resources Offers Domestic Alternatives CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE: American: WWR), an energy technology and battery-grade natural graphite…

Nanban Ventures Sends Letter Highlighting Steps Being Taken to Protect Investors

2 years ago

DALLAS--(BUSINESS WIRE)--Nanban Ventures LLC (“Nanban Ventures”), a Dallas-based venture capital firm investing in startups and other private companies that are…

Avistone Announces Phase II Results for Vebreltinib, a c-Met Tyrosine Kinase Inhibitor (TKI) at the European Society for Clinical Oncology (ESMO) Congress

2 years ago

BEIJING--(BUSINESS WIRE)--Avistone Biotechnology Co., Ltd. (“Avistone” or “the Company”), a clinical-stage biotechnology company focused on precision oncology therapeutics, announced preliminary…

ENHERTU® Demonstrated Clinically Meaningful Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial

2 years ago

Daiichi Sankyo and AstraZeneca’s ENHERTU showed a median progression-free survival of 6.9 months and median overall survival of 13.4 months…

Datopotamab Deruxtecan Improved Progression-Free Survival Versus Chemotherapy in Patients with Previously Treated Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial

2 years ago

Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced the risk of disease progression or death by 25% in overall population and…